molecules Article 1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study Danuta Branowska 1, Zbigniew Karczmarzyk 1,*, Ewa Woli ´nska 1, Waldemar Wysocki 1, Maja Morawiak 2 , Zofia Urba ´nczyk-Lipkowska 2 , Anna Bielawska 3 and Krzysztof Bielawski 3 1 Faculty of Exact and Natural Sciences, Siedlce University of Natural Sciences and Humanities, 3 Maja 54, 08-110 Siedlce, Poland;
[email protected] (D.B.);
[email protected] (E.W.);
[email protected] (W.W.) 2 Institute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland;
[email protected] (M.M.); zofi
[email protected] (Z.U.-L.) 3 Medical University of Bialystok, Department of Medicinal Chemistry and Drug Technology, J. Kilinskiego 1, 15-089 Bialystok, Poland;
[email protected] (A.B.);
[email protected] (K.B.) * Correspondence:
[email protected]; Tel.: +48-25-643-1017 Received: 24 March 2020; Accepted: 14 May 2020; Published: 16 May 2020 Abstract: In this study, we synthesized novel sulfonamides with a 1,2,4-triazine moiety according to pharmacophore requirements for biological activity. All the synthesized compounds were tested in vitro to verify whether they exhibited anticancer activity against the human breast cancer cell lines MCF-7 and MDA-MB-231. Among them, two most active ones, having IC50 values of 50 and 42 µM, respectively, were found to show higher anticancer activity than chlorambucil used as the reference in the in vitro tests. In addition, two other compounds, which had IC50 values of 78 and 91 µM, respectively, exhibited a similar level of activity as chlorambucil.